wr 1065 has been researched along with Glioma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grdina, DJ; Kataoka, Y; Murley, JS; Patel, R | 1 |
Calvin, DP; Grdina, DJ; Kataoka, Y; Murley, JS | 1 |
Grdina, DJ; Kataoka, Y; Khodarev, NN; Murley, JS; Weichselbaum, RR | 1 |
Berens, ME; Dougherty, DV; Doz, F; Rosenblum, ML; Spencer, DR | 1 |
4 other study(ies) available for wr 1065 and Glioma
Article | Year |
---|---|
Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines.
Topics: Amifostine; Cell Survival; Cytoprotection; Dose-Response Relationship, Radiation; Genes, p53; Glioma; Humans; Mercaptoethylamines; Mutation; Radiation-Protective Agents; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.
Topics: Amifostine; Cell Adhesion Molecules; Cells, Cultured; Endothelium, Vascular; Gene Expression; Glioma; Growth Substances; Humans; Mercaptoethylamines; Monokines; NF-kappa B; Radiation Dosage; Radiation-Protective Agents; Superoxide Dismutase; Transcriptional Activation; Tumor Cells, Cultured | 2002 |
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine.
Topics: Amifostine; Chemokine CCL5; Gene Expression Regulation; Genes, myb; Genes, myc; Glioma; Glutathione Transferase; Humans; Interleukin-2 Receptor alpha Subunit; Mercaptoethylamines; NF-kappa B; Oxidation-Reduction; Radiation-Protective Agents; Radiobiology; Receptors, Interleukin; Superoxide Dismutase; Tumor Cells, Cultured | 2002 |
Experimental basis for increasing the therapeutic index of carboplatin in brain tumor therapy by pretreatment with WR compounds.
Topics: Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Carboplatin; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Mercaptoethylamines; Tumor Cells, Cultured | 1991 |